{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:36:57Z","timestamp":1772120217307,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["N42\/DBS\/000256"],"award-info":[{"award-number":["N42\/DBS\/000256"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s43440-024-00686-2","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T22:16:38Z","timestamp":1734300998000},"page":"158-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advanced pharmacological and pharmacokinetic evaluation of 1,3 dimethylpurine-2,6-dione derivative (GR-14) with prominent mood-modulating activity in rats"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-350X","authenticated-orcid":false,"given":"Agnieszka","family":"Cios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-7801","authenticated-orcid":false,"given":"Gra\u017cyna","family":"Ch\u0142o\u0144-Rzepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5388-1214","authenticated-orcid":false,"given":"Magdalena","family":"Jastrz\u0119bska-Wi\u0119sek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-3085","authenticated-orcid":false,"given":"Krzysztof","family":"Pociecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2477-5607","authenticated-orcid":false,"given":"Katarzyna","family":"W\u00f3jcik-Pszczo\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1260-4253","authenticated-orcid":false,"given":"El\u017cbieta","family":"P\u0119kala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2383-3278","authenticated-orcid":false,"given":"Anna","family":"Weso\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"686_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jad.2020.12.035","volume":"281","author":"D Moreno-Agostino","year":"2021","unstructured":"Moreno-Agostino D, Wu Y-T, Daskalopoulou C, Hasan MT, Huisman M, Prina M. Global trends in the prevalence and incidence of depression: a systematic review and meta-analysis. J Affect Disord. 2021;281:235\u201343.","journal-title":"J Affect Disord"},{"key":"686_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s43045-023-00315-3","volume":"30","author":"SF Javaid","year":"2023","unstructured":"Javaid SF, Hashim IJ, Hashim MJ, Stip E, Samad MA, Ahbabi AA. Epidemiology of anxiety disorders: global burden and sociodemographic associations. Middle East Curr Psychiatry. 2023;30:44.","journal-title":"Middle East Curr Psychiatry"},{"issue":"7","key":"686_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/15622975.2020.1851052","volume":"22","author":"S Dodd","year":"2021","unstructured":"Dodd S, Bauer M, Carvalho AF, Eyre H, Fava M, Kasper S, et al. A clinical approach to treatment resistance in depressed patients: what to do when the usual treatments don\u2019t work well enough? World J Biol Psychiatry. 2021;22(7):483\u201394.","journal-title":"World J Biol Psychiatry"},{"key":"686_CR4","doi-asserted-by":"publisher","first-page":"109408","DOI":"10.1016\/j.biopha.2019.109408","volume":"120","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang Y, Du X, Ding T, Gong W, Liu F. Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors. Biomed Pharmacotherapy. 2019;120:109408.","journal-title":"Biomed Pharmacotherapy"},{"issue":"9","key":"686_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/ijnp\/pyab040","volume":"24","author":"SM Hags\u00e4ter","year":"2021","unstructured":"Hags\u00e4ter SM, Pettersson R, Pettersson C, Atanasovski D, N\u00e4slund J, Eriksson E. A complex impact of systemically administered 5-HT2A receptor ligands on conditioned fear. Int J Neuropsychopharmacol. 2021;24(9):749\u201357.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"686_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1177\/02698811231211228","volume":"37","author":"N Gottlieb","year":"2023","unstructured":"Gottlieb N, Li T-Y, Li, Young AH, Ra Stokes P. The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: a systematic review. J Psychopharmacol. 2023;37(12):1167\u201381.","journal-title":"J Psychopharmacol"},{"key":"686_CR7","first-page":"359","volume":"53","author":"G Ch\u0142o\u0144","year":"2001","unstructured":"Ch\u0142o\u0144 G, Paw\u0142owski M, Duszy\u0144ska B, Szaro A, Tatarczy\u0144ska E, K\u0142odzi\u0144ska A, et al. Synthesis, 5-HT1A and 5-H2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione. Pol J Pharmacol. 2001;53:359\u201368.","journal-title":"Pol J Pharmacol"},{"key":"686_CR8","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1016\/j.bmc.2007.05.017","volume":"15","author":"G Ch\u0142o\u0144-Rzepa","year":"2007","unstructured":"Ch\u0142o\u0144-Rzepa G, \u017bmudzki P, Zajdel P, Bojarski AJ, Duszy\u0144ska B, Nikiforuk A, et al. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT1A, 5-HT2A and 5-HT7 serotonin receptor ligands. Bioorg Med Chem. 2007;15:5239\u201350.","journal-title":"Bioorg Med Chem"},{"key":"686_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1734-1140(13)70960-5","volume":"65","author":"G Ch\u0142o\u0144-Rzepa","year":"2013","unstructured":"Ch\u0142o\u0144-Rzepa G, \u017bmudzki P, Sata\u0142a G, Duszy\u0144ska B, Partyka A, Wr\u00f3bel D, et al. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A and 5-HT7 receptor affinity and pharmacological evaluation. Pharmacol Rep. 2013;65:15\u201329.","journal-title":"Pharmacol Rep"},{"key":"686_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pharep.2013.12.014","volume":"66","author":"M Zygmunt","year":"2014","unstructured":"Zygmunt M, Sapa J, Ch\u0142o\u0144-Rzepa G, Zag\u00f3rska A, Siwek A, Paw\u0142owski M, et al. 7-3-Chlorophenylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity. Pharmacol Rep. 2014;66:505\u201310.","journal-title":"Pharmacol Rep"},{"key":"686_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.molstruc.2014.03.018","volume":"1067","author":"G Ch\u0142o\u0144-Rzepa","year":"2014","unstructured":"Ch\u0142o\u0144-Rzepa G, \u017bmudzki P, Paw\u0142owski M, Weso\u0142owska A, Sata\u0142a G, Bojarski AJ, et al. New 7-arylpiperazinylalkyl-8-morpholin-4-yl-purine-2,6-dione derivatives with anxiolytic activity - synthesis, crystal structure and structure-activity study. J Mol Struct. 2014;1067:243\u201351.","journal-title":"J Mol Struct"},{"key":"686_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bmc.2014.11.008","volume":"23","author":"A Partyka","year":"2015","unstructured":"Partyka A, Ch\u0142o\u0144-Rzepa G, Wasik A, Jastrz\u0119bska-Wi\u0119sek M, Bucki A, Ko\u0142aczkowski, et al. Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT1A receptor functional profile. Bioorg Med Chem. 2015;23:212\u201321.","journal-title":"Bioorg Med Chem"},{"key":"686_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ardp.201400392","volume":"348","author":"P \u017bmudzki","year":"2015","unstructured":"\u017bmudzki P, Ch\u0142o\u0144-Rzepa G, Bojarski AJ, Zygmunt M, Kazek G, Mordyl B, et al. Structure 5-HT receptor affinity relationship in a new group of 7-arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione. Arch Pharm Chem Life Sci. 2015;348:229\u201341.","journal-title":"Arch Pharm Chem Life Sci"},{"key":"686_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ardp.201500015","volume":"348","author":"G Ch\u0142o\u0144-Rzepa","year":"2015","unstructured":"Ch\u0142o\u0144-Rzepa G, Zag\u00f3rska A, Bucki A, Ko\u0142aczkowski M, Paw\u0142owski M, Sata\u0142a G, et al. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A\/5-HT2A\/5-HT7 and dopamine D2 receptors. Arch Pharm Chem Life Sci. 2015;348:242\u201353.","journal-title":"Arch Pharm Chem Life Sci"},{"key":"686_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/ardp.201600260","volume":"349","author":"G Ch\u0142o\u0144-Rzepa","year":"2016","unstructured":"Ch\u0142o\u0144-Rzepa G, Zag\u00f3rska A, \u017bmudzki P, Bucki A, Ko\u0142aczkowski M, Partyka A, et al. Aminoalkyl derivatives of 8-Alkoxypurine-2,6-diones: multifunctional 5-HT1A\/5-HT7 receptor ligands and PDE inhibitor with antidepressant activity. Arch Pharm Chem Life Sci. 2016;349:889\u2013903.","journal-title":"Arch Pharm Chem Life Sci"},{"key":"686_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/ardp.201600162","volume":"349","author":"P \u017bmudzki","year":"2016","unstructured":"\u017bmudzki P, Sata\u0142a G, Ch\u0142o\u0144-Rzepa G, Bojarski AJ, Kazek G, Siwek A, et al. Structure 5-HT\/D2 receptor affinity relationship of 1-arylpiperazinylalkyl derivatives of 8-dialkylamino-3,7-dimethyl-1 H-purine-2,6(3 H, 7 H)-dione. Arch Pharm Chem Life Sci. 2016;349:774\u201384.","journal-title":"Arch Pharm Chem Life Sci"},{"key":"686_CR17","doi-asserted-by":"crossref","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M et al. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Br J Pharmacol. 2020;177:3617\u20133624.","DOI":"10.1111\/bph.15193"},{"key":"686_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","volume":"51","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Bertin A, Jalfre M. Behavioural despair in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol. 1978;51:291\u20134.","journal-title":"Eur J Pharmacol"},{"key":"686_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00403989","volume":"21","author":"JR Vogel","year":"1971","unstructured":"Vogel JR, Beer B, Clody DE. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia (Berl). 1971;21:1\u20137.","journal-title":"Psychopharmacologia (Berl)"},{"key":"686_CR20","unstructured":"ICH. guideline M10 on bioanalytical method validation EMA\/CHMP\/ICH\/172948\/2019."},{"key":"686_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4172\/2157-7609.1000126","volume":"3","author":"JK Singh","year":"2012","unstructured":"Singh JK, Solanki A, Shirsath VS. Comparative in-vitro intrinsic clearance of imipramine in multiple species liver microsomes: human, rat, mouse and dog. J Drug Metab Toxicol. 2012;3:126.","journal-title":"J Drug Metab Toxicol"},{"key":"686_CR22","doi-asserted-by":"crossref","unstructured":"Weso\u0142owska A, Nikiforuk A. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. 2007;52(5):1274\u201383.","DOI":"10.1016\/j.neuropharm.2007.01.007"},{"key":"686_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuropharm.2014.05.036","volume":"85","author":"M Jastrz\u0119bska-Wi\u0119sek","year":"2014","unstructured":"Jastrz\u0119bska-Wi\u0119sek M, Siwek A, Kubacka M, Mogilski S, Wasik A, Ko\u0142aczkowski M, et al. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests. Neuropharmacology. 2014;85:253\u201362.","journal-title":"Neuropharmacology"},{"key":"686_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","volume":"70","author":"J Mark","year":"2003","unstructured":"Mark J, Millan MJ. The neurobiology and control of anxious states. Prog Neurobiol. 2003;70:83\u2013244.","journal-title":"Prog Neurobiol"},{"key":"686_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1023\/A:1018943613122","volume":"10","author":"B Davies","year":"1993","unstructured":"Davies B, Morris T. Physiological Parameters in Laboratory Animals and humans. Pharm Res. 1993;10:1093\u201395.","journal-title":"Pharm Res"},{"key":"686_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00204-020-02963-4","volume":"95","author":"N Todorovi\u0107 Vukoti\u0107","year":"2021","unstructured":"Todorovi\u0107 Vukoti\u0107 N, Dordevi\u0107 J, Peji\u0107 S, Dordevi\u0107 N, Pajovi\u0107 SB. Antidepressants\u2013 and antipsychotics\u2013induced hepatotoxicity. Arch Toxicol. 2021;95:767\u201389.","journal-title":"Arch Toxicol"},{"key":"686_CR27","doi-asserted-by":"crossref","unstructured":"Voican CS, Corruble E, Naveau S, Perlemuter G. Antidepressant-Induced Liver Injury: A Review for Clinicians. Am J Psychiatry. 2014, 171, 404\u2013415.Curr Drug Saf. 2013;8:207\u2013\u200923.","DOI":"10.1176\/appi.ajp.2013.13050709"},{"key":"686_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1124\/dmd.106.012294","volume":"35","author":"JC Kalvass","year":"2007","unstructured":"Kalvass JC, Maurer TS, Pollack GM. Use of plasma and brain unbound fractions to assess the extent of Brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo P-Glycoprotein efflux ratios. Drug Metab Dispos. 2007;35:660\u201366.","journal-title":"Drug Metab Dispos"},{"key":"686_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2478\/acph-2019-0024","volume":"69","author":"K S\u0142oczy\u0144ska","year":"2019","unstructured":"S\u0142oczy\u0144ska K, Gunia-Krzy\u017cak A, Koczurkiewicz P, W\u00f3jcik-Pszczo\u0142a K, \u017belaszczyk D, Popi\u00f3\u0142 J, et al. Metabolic stability and its role in the discovery of new chemical entities. Acta Pharm. 2019;69:345\u201361.","journal-title":"Acta Pharm"},{"key":"686_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13318-012-0098-5","volume":"38","author":"M Kajbaf","year":"2013","unstructured":"Kajbaf M, Ricci R, Zambon S, Fontana S. Contribution of rat intestinal metabolism to the xenobiotics clearance. Eur J Drug Metab Pharmacokinet. 2013;38:33\u201341.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"686_CR31","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1002\/jps.22179","volume":"99","author":"W Richmond","year":"2010","unstructured":"Richmond W, Wogan M, Isbell J, Gordon WP. Interstrain differences of in vitro metabolic stability and impact on early drug discovery. J Pharm Sci. 2010;99:4463\u20138.","journal-title":"J Pharm Sci"},{"key":"686_CR32","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/pharmaceutics13101542","volume":"13","author":"F Neumaier","year":"2021","unstructured":"Neumaier F, Zlatopolskiy BD, Neumaier B. Drug penetration into the Central Nervous System: pharmacokinetic concepts and in Vitro Model systems. Pharmaceutics. 2021;13:1542.","journal-title":"Pharmaceutics"},{"key":"686_CR33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1017\/S0265021507000154","volume":"24","author":"I Haller","year":"2007","unstructured":"Haller I, Lirk P, Keller C, Wang GK, Gerner P, Klimaschewki L. Differential neurotoxicity of tricyclic antidepressants and novel derivatives in vitro in a dorsal root ganglion cell culture model. Eur J Anaesthesiol. 2007;24:702\u201308.","journal-title":"Eur J Anaesthesiol"},{"key":"686_CR34","doi-asserted-by":"crossref","unstructured":"Smaga I, Krzy\u017canowska W, Pomierny B, Maciejewska A, Sk\u00f3rkowska A, Budziszewska B et al. Neurotoxicity in Depression. Handbook of Neurotoxicity. 2023:2085\u20132114.","DOI":"10.1007\/978-3-031-15080-7_176"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00686-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-024-00686-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00686-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:18:32Z","timestamp":1737317912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-024-00686-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1007\/s43440-024-00686-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5123241\/v1","asserted-by":"object"}]},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}